Cadent Therapeutics Company
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2010
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
Less than $1M
Register and Claim Ownership